Prognostic risk factors for graft failure following pancreas transplantation: results of multivariate analysis of data from the International Pancreas Transplant Registry
- 1 January 1990
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 3 (1) , 98-102
- https://doi.org/10.1111/j.1432-2277.1990.tb01901.x
Abstract
A multivariate analysis of prognostic factors for graft failure was performed on patients in the International Pancreas Transplant Registry. The analysis was restricted to the period January 1978 to June 1987 and included 764 patients. All patients had at least 1 year of follow-up. The following variables were studied: transplant year, continent (N. America, Europe, others), type of donor (cadaver, living related mismatched, living related HLA-identical), donor mismatch at the HLA A, B loci, donor mismatch at the DR loci, preservation time, kidney association (pancreas transplant alone, simultaneous pancreas and kidney transplant, pancreas after kidney transplant), whole versus segmental pancreatic transplant, graft duct management technique (polymer injection, enteric drainage, stomach drainage, bladder drainage), and immunosuppression. By stepwise, logistic regression analysis, we found that the following factors were predictive for 1-year graft function: donor mismatch at the DR loci (P = 0.0003), kidney association (P less than 0.0001), type of donor (P = 0.04), and immunosuppression (P = 0.0002). For donor mismatch at the DR loci, we found an odds ratio for success of 2.2 for 0 versus 2 mismatches. The odds for success were 2.9 for simultaneous pancreas and kidney transplant versus pancreas transplant alone. The best results--79% 1-year graft survival--were obtained for the combination of 0 mismatches at the DR loci, pancreas after kidney transplant, living related HLA-identical donor, and the immunosuppressive regimen consisting of cyclosporin, azathioprine, and prednisone. Patients receiving a pancreas transplant alone with 0 mismatches at the DR loci, living related HLA-identical donor, and triple immunosuppressive regimen had a predicted 1-year graft survival of 71%.Keywords
This publication has 10 references indexed in Scilit:
- Function of Pancreas Allografts More Than 1 Year Following TransplantationArchives of Surgery, 1989
- Who Should Get a Pancreas Transplant?Diabetes Care, 1988
- Pancreatic Transplantation as Treatment for IDDM: Proposed Candidate Criteria Before End-Stage Diabetic NephropathyDiabetes Care, 1988
- PANCREAS TRANSPLANTATION FOR DIABETESThe Lancet, 1988
- Combined Kidney and Pancreas Transplantation in DiabeticsArchives of Surgery, 1988
- IMPROVED RESULTS IN PANCREATIC TRANSPLANTATION BY AVOIDANCE OF NONIMMUNOLOGICAL GRAFT FAILURESTransplantation, 1987
- EXPERIMENTAL AND CLINICAL EXPERIENCE WITH URINE AMYLASE MONITORING FOR EARLY DIAGNOSIS OF REJECTION IN PANCREAS TRANSPLANTATIONTransplantation, 1987
- ESTIMATING ODDS RATIOS WITH CATEGORICALLY SCALED COVARIATES IN MULTIPLE LOGISTIC REGRESSION ANALYSIS1American Journal of Epidemiology, 1984
- Surgical Management of Reflux Strictures of the Esophagus in ChildhoodAnnals of Surgery, 1982
- Uremia—Nature's Immunosuppressive DeviceAnnals of Internal Medicine, 1965